CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


07-October-2014
Cerilliant now offers a Certified Spiking Solution® of XLR-11 4-Hydroxypentyl metabolite.

XLR-11 4-Hydroxypentyl metabol S-080
100 µg/mL in Methanol

A primary urinary metabolite of XLR-11, a popular third generation synthetic cannabinoid that purportedly can cause serious adverse health effects including kidney damage and stroke. XLR-11 is similar in structure to UR-144 and A-796,260, two compounds originally developed as pharmaceutical drug candidates due to their high affinity for the cannabinoid receptor CB2.
For those synthetic cannabinoids currently controlled at the federal level, our certified solution standards of these substances are DEA-exempt, allowing laboratories to place orders without additional regulatory paperwork. For US customers, state specific regulatory requirements may apply.



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn